Cargando…
The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs
Background: Gene replacement therapy (GRT) is a treatment method used to combat or prevent various diseases. Its high one-off cost constitutes a major obstacle for successful market access. This paper aims to assess and discuss the applicability of amortization in models, such as cost-effectiveness...
Autores principales: | Polek, Hubert, Janik, Justyna, Paterak, Ewelina, Dabbous, Monique, Pochopień, Michał, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334855/ https://www.ncbi.nlm.nih.gov/pubmed/37440980 http://dx.doi.org/10.1080/20016689.2023.2232648 |
Ejemplares similares
-
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
por: Pochopień, Michał, et al.
Publicado: (2021) -
Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment
por: Qiu, Tingting, et al.
Publicado: (2022) -
Exponential Automatic Amortized Resource Analysis
por: Kahn, David M., et al.
Publicado: (2020) -
President Trump’s prescription to reduce drug prices: from the campaign trail to American Patients First
por: Dabbous, Monique, et al.
Publicado: (2019) -
SAR Target Recognition via Meta-Learning and Amortized Variational Inference
por: Wang, Ke, et al.
Publicado: (2020)